FULC

Fulcrum Therapeutics Inc

FULC.US fulcrumtx.com + Research + Basket
CIK 0001680581
Employees 9
Phone 617 651 8851
Fiscal year end December
IPO Jul 18, 2019
Address 26 Landsdowne Street, Cambridge, MA, United States, 02139
3.68
-0.09 (-2.39%)
USD · NASDAQ
52-week range
2.83
15.74
Trading at 7% of the 52-week range
Market Cap
287.96M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
4.07
Div. Yield
N/A
% Institutions
102.10%
% Insiders
3.35%

1 Year

-53.2%

3 Year

+2.5%

10 Year

-72.7%
Description

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Failure Syndromes, novel fetal hemoglobin inducers, fibrotic disorders. It has licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Actions

Add an action for FULC.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Alexander C. Sapir CEO, President & Director 1967
Mr. Alan A. Musso C.M.A., CPA CFO, Treasurer & Principal Accounting Officer 1962
Mr. Curtis G. Oltmans J.D. Chief Legal Officer, Head of External Affairs & Corporate Secretary 1963
Dr. Bradley E. Bernstein M.D., Ph.D. Founder NA
Dr. Michael R. Green Founder NA
Dr. Rudolf Jaenisch M.D., Ph.D. Founder NA
Dr. Tsun-Huei Lee M.D., Ph.D. Founder 1964
Dr. Danny Reinberg Founder NA
Dr. Iain Fraser DPHIL Senior Vice President of Early Development NA
Bobby Riehle Ph.D. Head of Program Strategy & Vice President NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Jan 02, 2026 Robert J Gould N/A Sale 15.00K $11.87 $178.05K SEC
Dec 08, 2025 Ra Capital Management, L.P. N/A Sale 4.18M $13.98 $58.37M SEC
Nov 19, 2025 Robert J Gould N/A Sale 15.00K $11.03 $165.45K SEC
May 08, 2025 Greg Tourangeau N/A Sale 498.00 $5.06 $2.52K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Nantahala Capital Management, LLC 10.95M Jun 30, 2026 14.34% $0.67 259.01%
BlackRock Inc 8.82M Jun 30, 2026 11.55% $0.00 63.70%
EcoR1 Capital, LLC 6.55M Jun 30, 2026 8.58% $1.17 0.00%
TANG CAPITAL MANAGEMENT LLC 6.52M Jun 30, 2026 8.54% $1.08 0.00%
Suvretta Capital Management, LLC 3.68M Jun 30, 2026 4.82% $0.25 -43.90%
D. E. Shaw & Co LP 3.04M Jun 30, 2026 3.99% $0.01 87.55%
Citadel Advisors Llc 2.70M Jun 30, 2026 3.54% $0.00 109.25%
Vanguard Capital Management, LLC 2.70M Jun 30, 2026 3.53% $0.00 0.16%
Jane Street Group LLC 2.22M Jun 30, 2026 2.90% $0.00 614.36%
State Street Corp 2.04M Jun 30, 2026 2.67% $0.00 31.43%
Adage Capital Partners Gp LLC 2.00M Jun 30, 2026 2.62% $0.01 400.00%
GSK PLC 1.79M Jun 30, 2026 2.34% $1.09 0.00%
Qube Research & Technologies 1.75M Jun 30, 2026 2.29% $0.01 79.38%
Assenagon Asset Management SA 1.67M Jun 30, 2026 2.19% $0.00 39.92%
Renaissance Technologies Corp 1.65M Jun 30, 2026 2.16% $0.01 12,016.18%
ADAR1 Capital Management LLC 1.57M Jun 30, 2026 2.05% $0.26 1,098.70%
Millennium Management LLC 1.49M Jun 30, 2026 1.95% $0.00 316.81%
Geode Capital Management, LLC 1.43M Jun 30, 2026 1.88% $0.00 -3.66%
Marshall Wace Asset Management Ltd 1.36M Jun 30, 2026 1.78% $0.00 0.00%
UBS Group AG 1.25M Jun 30, 2026 1.64% $0.00 297.83%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 2.07M 2.72% ▲ 0.00% Sep 30, 2026
2 BlackRock Advantage Small Cap Core Instl 1.74M 2.28% ▲ 13.96% Sep 30, 2026
3 iShares Russell 2000 ETF 1.70M 2.23% ▼ 0.41% Oct 29, 2026
4 Fidelity Small Cap Index 646.38K 0.85% ▲ 0.30% Jul 31, 2026
5 iShares Russell 2000 Value ETF 625.27K 0.82% ▼ 0.31% Oct 28, 2026
6 Fidelity Enhanced Small Cap Core ETF 598.78K 0.78% ▲ 0.27% Oct 29, 2026
7 iShares Biotechnology ETF 576.71K 0.76% ▼ 0.19% Oct 29, 2026
8 Vanguard Russell 2000 ETF 396.02K 0.52% ▲ 16.46% Sep 30, 2026
9 Schwab US Small-Cap ETF™ 326.61K 0.43% ▲ 0.00% Oct 30, 2026
10 Strategic Advisers U.S. Total Stock 292.64K 0.38% ▲ 34.64% Aug 31, 2026

Financial Highlights

▼
Market Cap: $287.96M
EBITDA: $-85.40M
Book Value: $4.07
Earnings/Share: $-1.21
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -19.59%
ROE (TTM): -32.38%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Valuation Metrics

Enterprise Value: $-27.89M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 76.38M
Shares Float: 63.49M
% Insiders: 3.35%
% Institutions: 102.10%
Shares Short: 6.76M
Shares Short (Prior Month): 7.11M
Short Ratio: 4.44
Short % Float: 8.94%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-1.39M
Gross Profit
subtotal
$-1.39M
SG&A
adjust
$-28.67M
R&D
adjust
$-56.10M
Operating Income
subtotal
$-84.77M
Other / Non-Operating Items
adjust
$9.89M
Net Income
subtotal
$-74.88M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about FULC.US!